Dr. Brian C. Boulmay, MD

Dr. Boulmay practices at University Medical Center New Orleans in New Orleans, Louisiana, part of LCMC Health.

Dr. Boulmay's NPI, 1164505285, was assigned on October 23, 2006. Dr. Boulmay graduated from Louisiana State University School of Medicine in New Orleans in 2002. Dr. Boulmay holds Louisiana license MD.202052.

Dr. Boulmay's primary practice is University Medical Center New Orleans, at 2000 Canal Street, New Orleans, LA 70112 in Orleans Parish. The practice phone is (504) 702-3000.

Dr. Boulmay's primary practice is University Medical Center New Orleans in New Orleans, Louisiana, part of LCMC Health. Dr. Boulmay is also affiliated with East Jefferson General Hospital. The medical group on file is LSU Healthcare Network. Dmand AI also links Dr. Boulmay to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Boulmay practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Boulmay's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Boulmay's licenses on file in 2 states: Louisiana and Florida.

CMS data shows 132 Medicare services from Dr. Boulmay across 4 procedure codes in 2024, for 84 Medicare patients. Medicare paid $9,056 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 84 Medicare patients who saw Dr. Boulmay in 2024. The largest group is 65 to 74, with 34 patients. 75% of them have high blood pressure, and 63% have high cholesterol. 50% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Boulmay's median patient age at 68, with 49% women.

In 2024, Dr. Boulmay wrote 540 Medicare Part D claims for 87 patients. 70% of them were for generic drugs. CMS names the drug for 326 of them, across 20 drugs with 11 or more claims each, at $681,042 in total drug cost. In 2023, CMS named 328 claims across 15 drugs.

Dr. Boulmay accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Boulmay as offering telehealth.

Dmand AI links 20 papers to Dr. Boulmay, published from 2012 to 2024. 2019 was the busiest year, with 4. The most frequent topics are Tomography, X-Ray Computed, Fellowships and Scholarships and Lung Neoplasms. Dr. Boulmay has published most often in J La State Med Soc. Dr. Boulmay's most frequent co-authors are Shailender Bhatia, MD, Andrew S. Brohl, MD and Brent Allen Hanks, MD, PhD.

Dmand AI links Dr. Boulmay to 10 clinical trials, 6 of them phase 3 studies. 9 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Lung Neoplasms. National Cancer Institute (NCI) sponsors the most, 6.

CMS Open Payments shows 215 general payments to Dr. Boulmay from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $927.

Dr. Boulmay graduated from Louisiana State University School of Medicine in New Orleans in 2002.